➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Moodys
Merck
Boehringer Ingelheim
McKesson

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

GLYCINE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for glycine and what is the scope of patent protection?

Glycine is the generic ingredient in two branded drugs marketed by Baxter Hlthcare, B Braun, Hospira, and Icu Medical Inc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty drug master file entries for glycine. Four suppliers are listed for this compound.

Recent Clinical Trials for GLYCINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mansoura University HospitalPhase 4
University of MilanPhase 3
BMG PHARMAPhase 3

See all GLYCINE clinical trials

Medical Subject Heading (MeSH) Categories for GLYCINE

US Patents and Regulatory Information for GLYCINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Icu Medical Inc GLYCINE 1.5% IN PLASTIC CONTAINER glycine SOLUTION;IRRIGATION 018315-001 Approved Prior to Jan 1, 1982 AT RX No No   Start Trial   Start Trial   Start Trial
Hospira GLYCINE 1.5% IN PLASTIC CONTAINER glycine SOLUTION;IRRIGATION 017633-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
B Braun GLYCINE 1.5% IN PLASTIC CONTAINER glycine SOLUTION;IRRIGATION 016784-001 Approved Prior to Jan 1, 1982 AT RX No No   Start Trial   Start Trial   Start Trial
Baxter Hlthcare GLYCINE 1.5% IN PLASTIC CONTAINER glycine SOLUTION;IRRIGATION 018522-001 Feb 19, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Baxter
Colorcon
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.